世界の疼痛管理機器市場は、2021年の22億米ドルから2026年までに33億米ドルに達すると予測されており、予測期間中のCAGRは8.6％です。疼痛管理装置は、とりわけ、癌、神経障害、および筋骨格系障害などの様々なタイプの疾患状態に苦しむ患者における慢性および急性疼痛を管理するために使用されます。これらの装置は、日常の活動を行う能力を回復し、経口鎮痛薬の必要性を減らし、これらの状態に苦しむ患者の生活の質を改善します。しかし、製品のリコールと高い手続きコストが今後数年間の市場成長を阻む可能性があります。
疼痛管理機器市場は業績が低下し、その傾向は2020年12月下旬まで続きました。規制やガイドラインの不利な変更が、この業界の成長を妨げています。世界中の主な規制当局（CDC、WHO、MHRA、TGA、EMAなど）は、癌患者は健康な成人よりもCOVID-19感染のリスクが高いことを確認しています。したがって、スクリーニング、診断検査、および外科的処置は、病院および癌治療センターで厳しく制限または延期されます。これは、疼痛管理機器市場の混乱を引き起こすと予想されます。上記の要因によって、介護者や病院は待機的手術、スクリーニング手順、神経刺激療法の延期を余儀なくされるでしょう。しかし、2020年後半からは、輸液予約数の増加や、未処理分の解消や新規症例、医療サービスの全面再開などによるアブレーション手順などにより、市場は徐々に上昇してきました。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 1 PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
2.3 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020)
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021-2026)
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET
2.8 LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 17 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 PAIN MANAGEMENT DEVICES MARKET OVERVIEW
FIGURE 19 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER
4.2 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020)
FIGURE 20 NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 2020
4.3 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX
FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET
FIGURE 22 NORTH AMERICA DOMINATED THE MARKET IN 2020
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Rising demand for chronic pain management in home care settings
5.2.1.2 Growing number of surgical procedures performed
5.2.1.3 Rising prevalence of neurological disorders
5.2.1.3.1 Growing incidence of sports injuries and cancer
TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015-2019
5.2.1.4 Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries
5.2.2 MARKET RESTRAINTS
5.2.2.1 Product recalls
5.2.2.2 High procedural and purchase cost of pain management devices
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging countries
TABLE 3 RISING INCOME LEVELS IN EMERGING COUNTRIES
5.2.3.2 Expanding base of pain management clinics/centers across the globe
5.2.3.3 Use of pain medications as the first line of treatment for pain management
5.2.3.4 Stringent regulatory guidelines delay the adoption of novel devices
TABLE 4 PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE
5.3 REGULATORY LANDSCAPE
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES
5.3.1 NORTH AMERICA
5.3.1.1 US
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.3.1.2 Canada
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.2 EUROPE
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.3 ASIA PACIFIC
5.3.3.1 Japan
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.3.3.2 China
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.3.3.3 India
FIGURE 27 LATIN AMERICA: REGULATORY SCENARIO
5.3.3.4 Brazil
FIGURE 28 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 11 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.3.3.5 Mexico
FIGURE 29 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.4 VALUE CHAIN ANALYSIS
FIGURE 30 PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 31 PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT FROM NEW ENTRANTS
5.6.2 THREAT FROM SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 COMPETITIVE RIVALRY
5.7 INDUSTRY TRENDS
5.7.1 WEARABLE DEVICES
5.7.2 RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
TABLE 14 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD BILLION)
5.9 COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET
6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE (Page No. - 88)
6.1 INTRODUCTION
TABLE 15 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
6.2 NEUROSTIMULATION DEVICES
TABLE 16 NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 17 NEUROSTIMULATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
6.2.1.1 Extensive use in healthcare, low cost, and ease of use will favor market growth
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.2.2 SPINAL CORD STIMULATION
6.2.2.1 Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS
TABLE 19 SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.3 INFUSION PUMPS
6.3.1 HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT
TABLE 20 INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 21 INFUSION PUMPS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.3.2 INTRATHECAL INFUSION PUMPS
TABLE 22 INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.3.3 EXTERNAL INFUSION PUMPS
TABLE 23 EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.4 ABLATION DEVICES
TABLE 24 ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 25 ABLATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.4.1 RF ABLATION DEVICES
TABLE 26 RF ABLATION DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
6.4.2 CRYOABLATION DEVICES
TABLE 27 CRYOABLATION DEVICES MARKET SIZE, BY REGION,2019-2026 (USD MILLION)
7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION (Page No. - 99)
7.1 INTRODUCTION
TABLE 28 PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
7.2 NEUROPATHIC PAIN
7.2.1 HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN
TABLE 29 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
7.3 CANCER PAIN
TABLE 30 CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
7.4 FACIAL PAIN & MIGRAINE
TABLE 31 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
7.5 MUSCULOSKELETAL PAIN
TABLE 32 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 33 OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE (Page No. - 107)
8.1 INTRODUCTION
TABLE 34 PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
8.2 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES
8.2.1 OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES
TABLE 35 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
8.3 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES
TABLE 36 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
9 PAIN MANAGEMENT DEVICES MARKET, BY REGION (Page No. - 111)
9.1 INTRODUCTION
FIGURE 32 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
TABLE 38 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 39 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 40 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 41 NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 42 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 43 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 44 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.2.1 THE US
9.2.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market
TABLE 45 KEY MACROINDICATORS FOR THE US
TABLE 46 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 47 US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 48 US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 49 US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 50 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 51 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada
TABLE 52 KEY MACROINDICATORS FOR CANADA
TABLE 53 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 54 CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 55 CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 56 CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 57 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 58 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3 EUROPE
TABLE 59 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 60 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 61 EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 62 EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 63 EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 64 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 65 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Presence of leading pain management device manufacturers to drive market growth in Germany
TABLE 66 KEY MACROINDICATORS FOR GERMANY
TABLE 67 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 68 GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 69 GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 70 GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 71 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 72 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.2 FRANCE
TABLE 73 KEY MACROINDICATORS FOR FRANCE
TABLE 74 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 75 FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 76 FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 77 FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 78 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 79 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.3 THE UK
9.3.3.1 High burden of chronic pain in the country to propel the growth of the pain management devices market
TABLE 80 KEY MACROINDICATORS FOR THE UK
TABLE 81 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 82 UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 83 UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 84 UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 85 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 86 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growing demand for cost-effective home care services to support market growth
TABLE 87 KEY MACROINDICATORS FOR ITALY
TABLE 88 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,2019-2026 (USD MILLION)
TABLE 89 ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 90 ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 92 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 93 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of cancer to support the market for pain management devices market in Spain
TABLE 94 KEY MACROINDICATORS FOR SPAIN
TABLE 95 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 96 SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 97 SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 98 SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,2019-2026 (USD MILLION)
TABLE 99 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 100 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 101 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 102 ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 103 ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 105 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 106 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 34 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT
TABLE 107 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Large geriatric population in the country is driving the demand for infusion pumps
TABLE 114 KEY MACRO INDICATORS FOR JAPAN
TABLE 115 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 116 JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 117 JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 118 JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 120 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing investments in healthcare infrastructure development in the country to drive market growth in China
TABLE 121 KEY MACRO INDICATORS FOR CHINA
TABLE 122 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 123 CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 124 CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 125 CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 126 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 127 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for pain management devices market
TABLE 128 KEY MACRO INDICATORS FOR INDIA
TABLE 129 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 130 INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 131 INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 132 INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 133 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 134 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
9.4.4.1 High prevalence of chronic diseases in the region to drive the market for pain management devices
FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019)
TABLE 135 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)
FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)
FIGURE 37 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)
TABLE 136 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 142 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 143 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 144 LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 145 LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 146 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 147 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
TABLE 148 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZBY TYPE, 2019-2026 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,BY TYPE, 2019-2026 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019-2026 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 168)
10.1 OVERVIEW
FIGURE 38 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021)
10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 40 PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPANY EVALUATION QUADRANT
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 41 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)
10.5 COMPANY EVALUATION QUADRANT FOR START-UPS
10.5.1 PROGRESSIVE COMPANIES
10.5.2 DYNAMIC COMPANIES
10.5.3 STARTING BLOCKS
10.5.4 RESPONSIVE COMPANIES
FIGURE 42 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
10.6 COMPANY PRODUCT FOOTPRINT
TABLE 154 PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET
10.7 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
TABLE 155 GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 156 PRODUCT LAUNCHES (JANUARY 2018 - JUNE 2021)
10.8.2 DEALS
TABLE 157 DEALS (JANUARY 2018-JUNE 2021)
10.8.3 OTHER DEVELOPMENTS
TABLE 158 OTHER DEVELOPMENTS (JANUARY 2018- JUNE 2021)
11 COMPANY PROFILES (Page No. - 184)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 MEDTRONIC
TABLE 159 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.2 ABBOTT LABORATORIES
TABLE 160 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 161 ABBOTT LABORATORIES: PRODUCT OFFERINGS
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 162 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 163 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
11.1.4 STRYKER CORPORATION
TABLE 164 STRYKER: BUSINESS OVERVIEW
FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 165 STRYKER: PRODUCT OFFERINGS
11.1.5 BECTON, DICKINSON AND COMPANY
TABLE 166 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 167 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 48 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
11.1.7 BAXTER INTERNATIONAL INC.
TABLE 168 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 49 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
11.1.8 AVANOS MEDICAL, INC.
TABLE 169 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW
FIGURE 50 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020)
11.1.9 TELEFLEX, INC.
TABLE 170 TELEFLEX, INC.: BUSINESS OVERVIEW
FIGURE 51 TELEFLEX, INC.: COMPANY SNAPSHOT (2020)
11.1.10 SMITHS MEDICAL
TABLE 171 SMITHS MEDICAL: BUSINESS OVERVIEW
FIGURE 52 SMITHS MEDICAL: COMPANY SNAPSHOT (2020)
11.1.11 NIPRO CORPORATION
TABLE 172 NIPRO CORPORATION: BUSINESS OVERVIEW
FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2019)
11.1.12 MOOG INC.
TABLE 173 MOOG INC.: BUSINESS OVERVIEW
FIGURE 54 MOOG INC.: COMPANY SNAPSHOT (2020)
11.1.13 ATRICURE
TABLE 174 ATRICURE: BUSINESS OVERVIEW
FIGURE 55 ATRICURE: COMPANY SNAPSHOT
TABLE 175 ATRICURE: PRODUCT OFFERINGS
11.1.14 NEVRO CORP.
TABLE 176 NEVRO CORP: BUSINESS OVERVIEW
FIGURE 56 NEVRO CORP.: COMPANY SNAPSHOT
TABLE 177 NEVRO CORP: PRODUCT OFFERINGS
11.1.15 MICREL MEDICAL DEVICES SA
TABLE 178 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW
11.1.16 MINDRAY MEDICAL INTERNATIONAL LIMITED
TABLE 179 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
11.1.17 SHENZHEN MEDRENA BIOTECH CO., LTD.
TABLE 180 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW
11.1.18 EPIC MEDICAL
TABLE 181 EPIC MEDICAL: BUSINESS OVERVIEW
11.1.19 BIONESS
11.1.20 SOTERIX MEDICAL
11.2 OTHER PLAYERS
11.2.1 INFUTRONIX SOLUTIONS LLC
TABLE 182 INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW
11.2.2 GIMER MEDICAL
11.2.3 BLUEWIND MEDICAL
11.2.4 NEURONANO
11.2.5 MICROTRANSPONDER
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 241)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
